Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2002 2
2003 2
2004 4
2005 1
2006 3
2007 3
2011 2
2012 2
2013 1
2014 5
2015 4
2016 2
2017 3
2018 1
2019 1
2020 4
2021 1
2022 2
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
New Radiolabeled Exendin Analogues Show Reduced Renal Retention.
Joosten L, Frielink C, Jansen TJP, Lobeek D, Andreae F, Konijnenberg M, Heskamp S, Gotthardt M, Brom M. Joosten L, et al. Among authors: frielink c. Mol Pharm. 2023 Jul 3;20(7):3519-3528. doi: 10.1021/acs.molpharmaceut.3c00117. Epub 2023 Jun 2. Mol Pharm. 2023. PMID: 37265006 Free PMC article.
Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
Dorst DN, Smeets EMM, Klein C, Frielink C, Geijs D, Trajkovic-Arsic M, Cheung PFY, Stommel MWJ, Gotthardt M, Siveke JT, Aarntzen EHJG, van Lith SAM. Dorst DN, et al. Among authors: frielink c. Mol Pharm. 2023 Aug 7;20(8):4319-4330. doi: 10.1021/acs.molpharmaceut.3c00453. Epub 2023 Jul 24. Mol Pharm. 2023. PMID: 37485886 Free PMC article.
[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
de Koster EJ, van Engen-van Grunsven ACH, Bussink J, Frielink C, de Geus-Oei LF, Kusters B, Peters H, Oyen WJG, Vriens D; EFFECTS trial study group. de Koster EJ, et al. Among authors: frielink c. Mol Imaging Biol. 2023 Jun;25(3):483-494. doi: 10.1007/s11307-022-01776-4. Epub 2022 Oct 17. Mol Imaging Biol. 2023. PMID: 36253663 Free PMC article. Clinical Trial.
46 results